A Day Up For Adamas Pharmaceuticals, Inc.
Mon, Aug 10, 2020 at 05:34 PM
Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ) rocketted at $4.98, a gain of 31.7%. On Fri 07 Aug 20, ADMS:NASDAQ touched a New 2-Week High of $3.78. The stock appeared on our News Catalysts scanner on Thu 06 Aug 20 at 04:41 PM in the 'EARNINGS' category. From Fri 24 Jul 20, the stock recorded 50.00% Up Days and 36.36% Green Days
About Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ)
Adamas Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102.
Top 10 Gainers:
- Seres Therapeutics, Inc. (MCRB:NASDAQ), 389.22%
- Omeros Corporation (OMER:NASDAQ), 50.88%
- BiomX Inc. (PHGE:NYSEMKT), 42.1%
- Commercial Vehicle Group, Inc. (CVGI:NASDAQ), 37.04%
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 32.43%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 31.75%
- Trevena, Inc. (TRVN:NASDAQ), 31.51%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 30.51%
- LSB Industries, Inc. (LXU:NYSE), 29.75%
- Ocugen, Inc. (OCGN:NASDAQ), 28.18%